Reply to Cortegiani and Giarratano, "Untargeted Antifungal Treatment in Nonneutropenic Critically Ill Patients: Should Further Studies Be Performed Based on Trial Sequential Analysis Results?"
Antimicrob Agents Chemother
.
2018 Jun 26;62(7):e00891-18.
doi: 10.1128/AAC.00891-18.
Print 2018 Jul.
Authors
Yalin Dong
1
,
Yan Wang
2
Affiliations
1
Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China dongyalin@mail.xjtu.edu.cn.
2
Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.
PMID:
29945976
PMCID:
PMC6021654
DOI:
10.1128/AAC.00891-18
No abstract available
Keywords:
antifungal agents; trial sequential analysis; untargeted treatment.
Publication types
Letter
Comment
MeSH terms
Antifungal Agents*
Critical Illness
Economics, Pharmaceutical
Humans
Mycoses*
Network Meta-Analysis
Substances
Antifungal Agents